loading...| Preferred Name | atypical chronic myeloid leukemia, BCR-ABL1 negative | |
| Synonyms |
subacute myeloid leukemia aCML atypical CML atypical chronic myeloid leukemia |
|
| Definitions |
A myelodysplastic/myeloproliferative disease characterized by the principal involvement of the neutrophil series with leukocytosis and multilineage dysplasia. The neoplastic cells do not have a Philadelphia chromosome or the BCR/ABL fusion gene. The prognosis is usually poor. (WHO, 2001) Check for "https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/C3519" active clinical trials using this agent. ("http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C3519" NCI Thesaurus) |
|
| ID |
http://purl.bioontology.org/ontology/PDQ/CDR0000335175 |
|
| altLabel |
subacute myeloid leukemia aCML atypical CML atypical chronic myeloid leukemia |
|
| cui |
C1292772 |
|
| DATE FIRST PUBLISHED |
2003-09-24 |
|
| Date last modified |
2011-05-11 |
|
| definition |
A myelodysplastic/myeloproliferative disease characterized by the principal involvement of the neutrophil series with leukocytosis and multilineage dysplasia. The neoplastic cells do not have a Philadelphia chromosome or the BCR/ABL fusion gene. The prognosis is usually poor. (WHO, 2001) Check for "https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/C3519" active clinical trials using this agent. ("http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C3519" NCI Thesaurus) |
|
| MENU PARENT |
myelodysplastic/myeloproliferative neoplasms |
|
| MENU TYPE |
Clinical Trials--CancerType |
|
| NCI ID |
C3519 |
|
| notation |
CDR0000335175 |
|
| ORIG STY |
Neoplasm diagnosis Cancer stage |
|
| prefLabel |
atypical chronic myeloid leukemia, BCR-ABL1 negative |
|
| tui |
T191 |
|
| subClassOf |